BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 334337)

  • 1. Trial of polyunsaturated fatty acids in non-relapsing multiple sclerosis.
    Bates D; Fawcett PR; Shaw DA; Weightman D
    Br Med J; 1977 Oct; 2(6092):932-3. PubMed ID: 334337
    [No Abstract]   [Full Text] [Related]  

  • 2. Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis.
    Harbige LS; Sharief MK
    Br J Nutr; 2007 Oct; 98 Suppl 1():S46-53. PubMed ID: 17922959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyunsaturated fatty acids in multiple sclerosis.
    Bates D; Fawcett PR; Shaw DA; Weightman D
    Br Med J; 1979 Mar; 1(6164):683. PubMed ID: 435724
    [No Abstract]   [Full Text] [Related]  

  • 4. Polyunsaturated fatty acids and colchicine in multiple sclerosis.
    Br Med J; 1979 Feb; 1(6160):411-2. PubMed ID: 761034
    [No Abstract]   [Full Text] [Related]  

  • 5. Polyunsaturated fatty acids and colchicine in multiple sclerosis.
    Horrobin DF; Botez T; Botez MI
    Br Med J; 1979 Jan; 1(6157):199-200. PubMed ID: 421025
    [No Abstract]   [Full Text] [Related]  

  • 6. Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis.
    Mehta LR; Dworkin RH; Schwid SR
    Nat Clin Pract Neurol; 2009 Feb; 5(2):82-92. PubMed ID: 19194388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MaxEPA in multiple sclerosis.
    French JM
    Br J Clin Pract Suppl; 1984; 31():117-21. PubMed ID: 6091716
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple sclerosis and MaxEPA.
    Cendrowski W
    Br J Clin Pract; 1986 Sep; 40(9):365-7. PubMed ID: 3542002
    [No Abstract]   [Full Text] [Related]  

  • 9. Polyunsaturated fatty acids in multiple sclerosis.
    Sinclair H
    Br Med J; 1977 Nov; 2(6096):1217. PubMed ID: 589093
    [No Abstract]   [Full Text] [Related]  

  • 10. Supplementation of polyunsaturated fatty acids in multiple sclerosis.
    Gallai V; Sarchielli P; Trequattrini A; Murasecco D
    Ital J Neurol Sci; 1992 Jun; 13(5):401-7. PubMed ID: 1517064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unsaturated fatty acids in multiple sclerosis.
    Mertin J; Shenton BK; Field EJ
    Br Med J; 1973 Jun; 2(5869):777-8. PubMed ID: 4718333
    [No Abstract]   [Full Text] [Related]  

  • 12. [Unsaturated fatty acids in the immunology and therapy of multiple sclerosis].
    Cendrowski W
    Pol Tyg Lek; 1982 Apr; 37(8):225-7. PubMed ID: 7050947
    [No Abstract]   [Full Text] [Related]  

  • 13. Essential fatty acids and related molecular and cellular mechanisms in multiple sclerosis: new looks at old concepts.
    Mayer M
    Folia Biol (Praha); 1999; 45(4):133-41. PubMed ID: 10732726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis.
    Bates D; Fawcett PR; Shaw DA; Weightman D
    Br Med J; 1978 Nov; 2(6149):1390-1. PubMed ID: 363236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory and therapeutic effects of Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.
    Rezapour-Firouzi S; Arefhosseini SR; Mehdi F; Mehrangiz EM; Baradaran B; Sadeghihokmabad E; Mostafaei S; Fazljou SM; Torbati MA; Sanaie S; Zamani F
    Complement Ther Med; 2013 Oct; 21(5):473-80. PubMed ID: 24050582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis: treatment and prophylaxis.
    Field EJ
    J R Soc Med; 1979 Jul; 72(7):487-8. PubMed ID: 552545
    [No Abstract]   [Full Text] [Related]  

  • 17. [Polyunsaturated fatty acids and their metabolites in chronic inflammatory bowel disease].
    Cabré i Gelada E; Esteve i Comas M
    Gastroenterol Hepatol; 1995 Dec; 18(10):515-25. PubMed ID: 8548588
    [No Abstract]   [Full Text] [Related]  

  • 18. [Polyunsaturated fatty acids for multiple sclerosis treatment: scientific evidence].
    Kong-González M; Pérez-Cortéz JG; Hernández-Girón C; Macías-Morales N; Flores-Aldana M
    Medwave; 2015 Jan; 15(1):e6062. PubMed ID: 25628005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyunsaturated fatty acids and neurological diseases.
    Salvati S; Attorri L; Di Benedetto R; Di Biase A; Leonardi F
    Mini Rev Med Chem; 2006 Nov; 6(11):1201-11. PubMed ID: 17100631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyunsaturated fatty acids in multiple sclerosis therapy.
    Wergeland S; Torkildsen Ø; Bø L; Myhr KM
    Acta Neurol Scand Suppl; 2012; (195):70-5. PubMed ID: 23278660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.